Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02495753 · ClinicalTrials.gov registry record · NA
Vaginal Cleansing Before Cesarean Delivery to Reduce Infection
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 608
- Enrollment target
NCT02495753: Completed NA study, sponsored by Washington University School of Medicine.
NCT02495753 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 608 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02495753, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 608 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.
Primary Outcome
Maternal fever, endometritis, intrabdominal infection or abscess, wound complication within 30 days of delivery or wound infection.
Interventions
- PROCEDURE Vaginal Cleansing
- PROCEDURE Abdominal Cleansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2015-08 |
| Est. Completion | 2021-04 |
| Phase | NA |
What the finished NCT02495753 record still lists
NCT02495753 is an interventional study that assigns participants to a tested intervention. The registered 608 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Vaginal Cleansing is the first listed.
NCT02495753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02495753 about?
NCT02495753 is a clinical study titled "Vaginal Cleansing Before Cesarean Delivery to Reduce Infection". The purpose of this study is to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.
What is the current status of trial NCT02495753?
This trial is currently completed. It is a NA study. The enrollment target is 608 participants. The study started on 2015-08. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02495753?
The interventions under investigation include: Vaginal Cleansing (PROCEDURE), Abdominal Cleansing (PROCEDURE).
Who is sponsoring clinical trial NCT02495753?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02495753's enrollment target sits among peer trials
608 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia